These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21936634)

  • 1. Modeled microgravity increases filamentation, biofilm formation, phenotypic switching, and antimicrobial resistance in Candida albicans.
    Searles SC; Woolley CM; Petersen RA; Hyman LE; Nielsen-Preiss SM
    Astrobiology; 2011 Oct; 11(8):825-36. PubMed ID: 21936634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
    Nailis H; Vandenbosch D; Deforce D; Nelis HJ; Coenye T
    Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
    Bruzual I; Riggle P; Hadley S; Kumamoto CA
    J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Candida albicans Ddr48 protein is essential for filamentation, stress response, and confers partial antifungal drug resistance.
    Dib L; Hayek P; Sadek H; Beyrouthy B; Khalaf RA
    Med Sci Monit; 2008 Jun; 14(6):BR113-121. PubMed ID: 18509269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives.
    Shafreen RM; Muthamil S; Pandian SK
    Appl Microbiol Biotechnol; 2014 Aug; 98(15):6775-85. PubMed ID: 24723295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; López-Ribot JL
    Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Genomic Analysis of Candida albicans Adherence Reveals a Key Role for the Arp2/3 Complex in Cell Wall Remodelling and Biofilm Formation.
    Lee JA; Robbins N; Xie JL; Ketela T; Cowen LE
    PLoS Genet; 2016 Nov; 12(11):e1006452. PubMed ID: 27870871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida albicans switch phenotypes display differential levels of fitness.
    Vargas K; Srikantha R; Holke A; Sifri T; Morris R; Joly S
    Med Sci Monit; 2004 Jul; 10(7):BR198-206. PubMed ID: 15232493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast genomic expression patterns in response to low-shear modeled microgravity.
    Sheehan KB; McInnerney K; Purevdorj-Gage B; Altenburg SD; Hyman LE
    BMC Genomics; 2007 Jan; 8():3. PubMed ID: 17201921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of IgY against Candida albicans and Candida spp. Adherence and Biofilm Formation.
    Fujibayashi T; Nakamura M; Tominaga A; Satoh N; Kawarai T; Narisawa N; Shinozuka O; Watanabe H; Yamazaki T; Senpuku H
    Jpn J Infect Dis; 2009 Sep; 62(5):337-42. PubMed ID: 19762981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the glycolytic flux and hypoxia adaptation to efficient biofilm formation by Candida albicans.
    Bonhomme J; Chauvel M; Goyard S; Roux P; Rossignol T; d'Enfert C
    Mol Microbiol; 2011 May; 80(4):995-1013. PubMed ID: 21414038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin alters the expression of drug efflux pumps and confers amphotericin B tolerance in Candida albicans.
    O'Keeffe J; Kavanagh K
    Anticancer Res; 2004; 24(2A):405-8. PubMed ID: 15152937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased filamentous growth of Candida albicans in simulated microgravity.
    Altenburg SD; Nielsen-Preiss SM; Hyman LE
    Genomics Proteomics Bioinformatics; 2008 Mar; 6(1):42-50. PubMed ID: 18558384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC; Culici M; Alfieri M; Dal Sasso M
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents.
    Harrison JJ; Turner RJ; Ceri H
    FEMS Microbiol Lett; 2007 Jul; 272(2):172-81. PubMed ID: 17490429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to Amphotericin B.
    Yang C; Gong W; Lu J; Zhu X; Qi Q
    J Oral Pathol Med; 2010 Feb; 39(2):182-7. PubMed ID: 19656268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida albicans MTLalpha tup1Delta mutants can reversibly switch to mating-competent, filamentous growth forms.
    Park YN; Morschhäuser J
    Mol Microbiol; 2005 Dec; 58(5):1288-302. PubMed ID: 16313617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.